Antipsychotic Medication Adherence and Healthcare Services Utilization in Two Cohorts of Patients with Serious Mental Illness

References

• National Institute of Mental Health. NIMH » Mental Illness. Mental illness statistics. Available from: https://www.nimh.nih.gov/health/statistics/mental-illness.shtml. Accessed March 13,2018.
   Google Scholar
• Ahrnsbrak R, Bose J, Hedden SL, Lipari RN, Park-Lee E. Key Substance Use and Mental Health Indicators in the United States: Results from the 2016 National Survey on Drug Use and Health. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017.
   Google Scholar
• Gogtay N, Vyas NS, Testa R, Wood SJ, Pantelis C. Age of onset of schizophrenia: perspectives from structural neuroimaging studies. Schizophr Bull. 2011;37:504–513. doi:10.1093/schbul/sbr030
   PubMed Web of Science ®Google Scholar
• Häfner H, Maurer K, Löffler W, et al. The epidemiology of early schizophrenia: influence of age and gender on onset and early course. Br J Psychiatry Suppl. 1994;23:29–38. doi:10.1192/S0007125000292714
   PubMedGoogle Scholar
• Insel TR. Assessing the economic costs of serious mental illness. Am J Psychiatry. 2008;165:663–665. doi:10.1176/appi.ajp.2008.08030366
   PubMed Web of Science ®Google Scholar
• Trautmann S, Rehm J, Wittchen H. The economic costs of mental disorders. EMBO Rep. 2016;17:1245–1249. doi:10.15252/embr.201642951
   PubMed Web of Science ®Google Scholar
• O’Connor E, Rossom RC, Henninger M, Groom HC, Burda BU. Primary care screening for and treatment of depression in pregnant and postpartum women: evidence report and systematic review for the U.S. Preventive Services Task Force. JAMA. 2016;315:388–406. doi:10.1001/jama.2015.18948
   PubMed Web of Science ®Google Scholar
• Agency for Healthcare Research and Quality. Interventions for Adult Offenders with Serious Mental Illness; 2013.
   Google Scholar
• World Health Organization. Pharmacological Treatment of Mental Disorders in Primary Health Care; 2009.
   Google Scholar
• Baldwin DS, Anderson IM, Nutt DJ, et al. Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder, and obsessive-compulsive disorder: A revision of the 2005 guidelines from the British Association for Psychopharmacology. J Psychopharmacol. 2014;28:403–439.
   PubMed Web of Science ®Google Scholar
• Sajatovic M, Valenstein M, Blow FC, Ganoczy D, Ignacio RV. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord. 2006;8:232–241. doi:10.1111/bdi.2006.8.issue-3
   PubMed Web of Science ®Google Scholar
• Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty JP. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence. 2017;11:449–468. doi:10.2147/PPA.S124658
   PubMed Web of Science ®Google Scholar
• Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiatry. 2002;63:892–909. doi:10.4088/JCP.v63n1007
   PubMed Web of Science ®Google Scholar
• Shafrin J, Forma F, Scherer E, Hatch A, Vytlacil E, Lakdawalla D. The cost of adherence mismeasurement in serious mental illness: a claims-based analysis. Am J Manag Care. 2017;23(5):e156–e163.
   PubMed Web of Science ®Google Scholar
• Luciano A, Meara E. The employment status of people with mental illness: national survey data from 2009 and 2010. Psychiatr Serv Wash DC. 2014;65:1201–1209. doi:10.1176/appi.ps.201300335
   Web of Science ®Google Scholar
• Rosenheck R, Leslie D, Keefe R, et al. Barriers to employment for people with schizophrenia. Am J Psychiatry. 2006;163:411–417. doi:10.1176/appi.ajp.163.3.411
   PubMed Web of Science ®Google Scholar
• Hor K, Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J Psychopharmacol Oxf Engl. 2010;24:81–90. doi:10.1177/1359786810385490
   PubMed Web of Science ®Google Scholar
• Jamison KR. Suicide and bipolar disorder. J Clin Psychiatry Suppl. 2000;61(9):47–51.
   Web of Science ®Google Scholar
• Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8:e016982. doi:10.1136/bmjopen-2017-016982
   PubMed Web of Science ®Google Scholar
• Vergouwen ACM, Bakker A, Katon WJ, Verheij TJ, Koerselman F. Improving adherence to antidepressants: a systematic review of interventions. J Clin Psychiatry. 2003;64:1415–1420. doi:10.4088/JCP.v64n1203
   PubMed Web of Science ®Google Scholar
• Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J Clin Psychiatry. 2002;63:384–390. doi:10.4088/JCP.v63n0502
   PubMed Web of Science ®Google Scholar
• Chakrabarti S. Treatment-adherence in bipolar disorder: a patient-centred approach. World J Psychiatry. 2016;6:399–409. doi:10.5498/wjp.v6.i4.399
   PubMed Web of Science ®Google Scholar
• Ascher-Svanum H, Zhu B, Faries D, Lacro JP, Dolder CR. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. J Clin Psychiatry. 2006;67:1114–1123. doi:10.4088/JCP.v67n0715
   PubMed Web of Science ®Google Scholar
• Chapman SCE, Horne R. Medication nonadherence and psychiatry.Curr Opin Psychiatry. 2013;26:446–452. doi:10.1097/YCO.0b013e3283642da4
   PubMed Web of Science ®Google Scholar
• MacEwan J, Forma F, Shafrin J, Hatch A, Lakdawalla D, Lindenmayer JP. Patterns of adherence to oral atypical antipsychotics among patients diagnosed with schizophrenia. J Manag Care Spec Pharm. 2016;22(11):1349–1361. doi:10.18553/jmcp.2016.22.11.1349
   PubMedGoogle Scholar
• Periodic Review Status for Inovalon’s Medical Outcomes Research for Effectiveness and Economics Registry (MORE2 Registry®), Letter of Determination, Daniel C. Barth-Jones, M.P.H., Ph.D., President, dEpid/dt Consulting, Inc. and Assistant Professor of Clinical Epidemiology, Mailman School of Public Health, Columbia University, October 27, 2017.
   Google Scholar
• Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–619. doi:10.1016/0895-4356(92)90133-8
   PubMed Web of Science ®Google Scholar
• Kessler RC, Amminger GP, Aguilar-Gaxiola S, et al. Age of onset of mental disorders: a review of recent literature. Curr Opin Psychiatry. 2007;20:359–364. doi:10.1097/YCO.0b013e32816ebc8c
   PubMed Web of Science ®Google Scholar
• National Alliance on Mental Illness. Bipolar disorder. Available from: https://www.nami.org/Learn-More/Mental-Health-Conditions/Bipolar-Disorder. Accessed July 5, 2018.
   Google Scholar
• American Psychiatric Association. Warning signs of mental illness. Available from: https://www.psychiatry.org/patients-families/warning-signs-of-mental-illness. Accessed July 5, 2018.
   Google Scholar
• Walker ER, Cummings JR, Hockenberry JM, Druss BG. Insurance status, use of mental health services, and unmet need for mental health care in the United States. Psychiatr Serv Wash DC. 2015;66:578–584. doi:10.1176/appi.ps.201400248
   PubMed Web of Science ®Google Scholar